CCR10 and hepatocellular carcinoma: Also, CCR10 was found to be significantly upregulated in inflammation-driven HCC tumors and in hepatocytes of paracancerous tissue, where it is secreted, activating PI3K/AKT signaling, inhibiting apoptosis, and promoting cell proliferation, leading to HCC onset [256].